4.6 Review

Role of autotaxin in systemic lupus erythematosus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis

Dinesh Khanna et al.

Summary: The study aimed to investigate the efficacy, safety, and tolerability of ziritaxestat in patients with early dcSSc. The results showed that ziritaxestat significantly reduced the modified Rodnan skin score compared to placebo and was well tolerated. Biomarker analysis suggested that ziritaxestat may reduce fibrosis. In conclusion, this study highlights the importance of ziritaxestat in improving skin involvement in patients with dcSSc.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials

Edward M. Vital et al.

Summary: This study characterizes the efficacy and safety of anifrolumab in patients with moderate-to-severe SLE. It shows that anifrolumab has consistent efficacy and safety across different subgroups of patients. However, the limited sample size in some subgroups limits the conclusions about treatment benefit with anifrolumab.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Multidisciplinary Sciences

LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation

Kimberly N. Kremer et al.

Summary: Cancer and chronic infections increase levels of lysophosphatidic acid (LPA), which impairs T cell function. Targeting LPA signaling can rescue T cell function and promote antiviral and antitumor immunity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Multidisciplinary Sciences

Urine autotaxin levels reflect the disease activity of sarcoidosis

Koji Murakami et al.

Summary: This study found that urine ATX levels may be a novel and useful indicator for assessing disease activity in sarcoidosis.

SCIENTIFIC REPORTS (2022)

Article Rheumatology

Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus

Stephan Hasse et al.

Summary: In this study, we found that patients with systemic lupus erythematosus (SLE) had increased levels of platelet activation markers, which were associated with disease activity. Additionally, we discovered a correlation between high levels of phosphatidylserine positive red blood cell extracellular vesicles (PS+ REVs) and a higher incidence of past thrombotic events.

LUPUS SCIENCE & MEDICINE (2022)

Article Immunology

Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications

Juan Liu et al.

Summary: This review discusses the activation and functional changes of dendritic cells (DCs) during the development of systemic lupus erythematosus (SLE) and explores the therapeutic potential of targeting DCs in the treatment of SLE.

JOURNAL OF AUTOIMMUNITY (2022)

Article Immunology

Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies

Hao Li et al.

Summary: T cell abnormalities are closely associated with the development of SLE, including numerical and functional disturbances in CD4+ and CD8+ T cells, which lead to immune dysregulation and tissue infiltration. These abnormalities are mainly due to signaling defects, metabolic alterations, and epigenetic changes. Novel strategies to correct T cell abnormalities show promise for SLE treatment.

JOURNAL OF AUTOIMMUNITY (2022)

Review Oncology

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer

Sha She et al.

Summary: This review summarizes the physiological function of ATX and the ATX-LPA axis in liver cancer, analyzes their role in tumorigenesis and metastasis, and discusses therapeutic strategies targeting the ATX-LPA axis, paving the way for new therapeutic developments.

FRONTIERS IN ONCOLOGY (2022)

Article Rheumatology

Autotaxin is a potential link between genetic risk factors and immunological disturbances of plasmacytoid dendritic cells in systematic lupus erythematosus

Yumi Tsuchida et al.

Summary: This study demonstrated that autotaxin plays a critical role in connecting genetic risk factors of SLE to disease pathogenesis in plasmacytoid dendritic cells (pDCs). The increased expression of ENPP2 in pDCs from patients with SLE may be caused by increased expression of interferon-associated genes and increased binding of STAT3 complexes to the regulatory region of ENPP2, highlighting the potential mechanism by which autotaxin contributes to the development of SLE.
Review Rheumatology

Emerging concepts of type I interferons in SLE pathogenesis and therapy

Antonios Psarras et al.

Summary: This review discusses the role and therapeutic application of type I interferons in the pathogenesis of systemic lupus erythematosus (SLE). Recent evidence has overturned long-held assumptions about the regulation and pathological mechanisms of interferons, providing a new perspective on SLE pathogenesis. The study also highlights the importance of type I interferons in the early stages of the disease and non-haematopoietic cellular sources. These findings suggest the potential of interferon-blocking therapies for treating SLE.

NATURE REVIEWS RHEUMATOLOGY (2022)

Article Immunology

Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue

Lianne E. Kwant et al.

Summary: Lupus nephritis is a serious complication of systemic lupus erythematosus, characterized by immune complex deposition in glomeruli, leading to immune cell infiltration and kidney injury. Monocytes and macrophages play important roles in the inflammatory process and may serve as specific therapeutic targets for controlling lupus nephritis.

AUTOIMMUNITY REVIEWS (2022)

Article Gastroenterology & Hepatology

Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C

Kazuya Takemura et al.

Summary: This study analyzed the correlation between ATX and liver fibrosis in pre- and post-treatment patients with HCV infection. ATX is established as a biomarker for predicting liver fibrosis, but separate cutoff values should be established for different treatment stages.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Rheumatology

Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A1 in patients with lupus nephritis

Yasunori Iwata et al.

Summary: In patients with lupus nephritis, serum levels of ATX and PS-PLA(1) were significantly higher, with lower levels of ATX associated with higher activity and chronicity scores. These results could be influenced by treatment, and further research is needed to clarify the clinical utility of these biomarkers in lupus nephritis.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)

Article Immunology

Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters

Katarzyna M. Grzes et al.

Summary: IL-3-induced expression of amino acid transporters in pDCs activates mTORC1 nutrient sensor, leading to cytokine production. Inhibition of amino acid transporters and ENPP2 can block cytokine production, providing additional therapeutic targets for autoimmune diseases involving pDCs.

IMMUNITY (2021)

Article Multidisciplinary Sciences

Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis

Baasanjav Uranbileg et al.

Summary: The study indicated a potential link between elevated levels of LPC and LPA in cerebrospinal fluid and lumbar spinal canal stenosis. The use of an ATX inhibitor in a compression of DRG model showed promising results in alleviating pain symptoms and reducing populations of microglia and astrocytes in the spinal dorsal horn.

SCIENTIFIC REPORTS (2021)

Review Immunology

Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target

Konstantinos Ntatsoulis et al.

Summary: The study indicates that severe COVID-19 shares similarities with ARDS and ILDs and suggests ATX as a potential common pathologic link and therapeutic target.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Enpp2 Expression by Dendritic Cells Is a Key Regulator in Migration

Jun-Ho Lee et al.

Summary: The study investigated the biological effects of Enpp2 on dendritic cells (DCs) and found that Enpp2 is essential for the migration capacity of mature DCs (mDCs) to lymph nodes, enhancing our understanding of DC biology. Regulating Enpp2 may improve DC migration to lymph nodes, thereby enhancing the effectiveness of cancer vaccines based on DCs.

BIOMEDICINES (2021)

Review Cell Biology

The Expression Regulation and Biological Function of Autotaxin

Xiaotian Zhang et al.

Summary: Autotaxin plays a crucial role in cancer development by promoting cell proliferation, migration, and survival through producing LPA, as well as increasing the expression of inflammation-related circuits that impact patients' prognosis. ATX is considered a potential therapeutic target for cancer, with a number of ATX inhibitors currently developed.
Article Biochemistry & Molecular Biology

Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells

Ioanna Nikitopoulou et al.

Summary: The study suggests a potential role for the ATX and LPA signaling pathway in systemic inflammation and related vascular damage in COVID-19 patients. Clinical findings demonstrate that dexamethasone treatment can reduce ATX levels, potentially providing a beneficial impact on the treatment of COVID-19 patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification

Kuniyuki Kano et al.

Summary: The study developed an optimized plasma preparation method to accurately measure LPA concentrations, revealing lower levels of LPA in humans and mice than previously reported. The increased accuracy also allowed for the detection of circadian rhythms in certain LPA species in mouse plasma.

JOURNAL OF LIPID RESEARCH (2021)

Article Rheumatology

Living with systemic lupus erythematosus in 2020: a European patient survey

Alain Cornet et al.

Summary: This study aimed to analyze the burden of Systemic Lupus Erythematosus (SLE) in Europe in 2020 from the perspective of patients. Data from 4375 SLE patients in 35 European countries showed significant impact on patients' lives, including common joint and skin symptoms, diagnostic delays, and inadequate treatment.

LUPUS SCIENCE & MEDICINE (2021)

Article Medicine, General & Internal

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

Eric F. Morand et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Rheumatology

Physiopathology of pain in systemic erythematosus lupus

Louise P. Nichilatti et al.

Article Medical Laboratory Technology

Urinary autotaxin concentrations are associated with kidney injury

Yoshifumi Morita et al.

CLINICA CHIMICA ACTA (2020)

Article Cardiac & Cardiovascular Systems

Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction

Himi Tripathi et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)

Review Biochemistry & Molecular Biology

Emerging roles of lysophospholipids in health and disease

Shu Ting Tan et al.

PROGRESS IN LIPID RESEARCH (2020)

Review Rheumatology

EULAR recommendations for the management of antiphospholipid syndrome in adults

Maria G. Tektonidou et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Review Immunology

Autotaxin and chronic inflammatory diseases

Christiana Magkrioti et al.

JOURNAL OF AUTOIMMUNITY (2019)

Article Biochemistry & Molecular Biology

Autotaxin determines colitis severity in mice and is secreted by B cells in the colon

Songbai Lin et al.

FASEB JOURNAL (2019)

Article Medical Laboratory Technology

Performance of autotaxin as a serum marker for liver fibrosis

Hitoshi Ikeda et al.

ANNALS OF CLINICAL BIOCHEMISTRY (2018)

Article Gastroenterology & Hepatology

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease

Naoyuki Fujimori et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Review Rheumatology

Systemic lupus erythematosus biomarkers: the challenging quest

Cristina Arriens et al.

RHEUMATOLOGY (2017)

Article Rheumatology

An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis

Flavia V. Castelino et al.

ARTHRITIS & RHEUMATOLOGY (2016)

Article Immunology

Predominant role of plasmacytoid dendritic cells in stimulating systemic autoimmunity

Xinfang Huang et al.

FRONTIERS IN IMMUNOLOGY (2015)

Article Multidisciplinary Sciences

Regulation of T Cell Motility In Vitro and In Vivo by LPA and LPA2

Sara A. Knowlden et al.

PLOS ONE (2014)

Article Rheumatology

Necessity of Lysophosphatidic Acid Receptor 1 for Development of Arthritis

Yoshishige Miyabe et al.

ARTHRITIS AND RHEUMATISM (2013)

Article Medical Laboratory Technology

Decrease in circulating autotaxin by oral administration of prednisolone

Hayakazu Sumida et al.

CLINICA CHIMICA ACTA (2013)

Review Medical Laboratory Technology

Autotaxin in liver fibrosis

Hitoshi Ikeda et al.

CLINICA CHIMICA ACTA (2012)

Article Immunology

Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis

Ioanna Nikitopoulou et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Article Biochemistry & Molecular Biology

Binding of Autotaxin to Integrins Localizes Lysophosphatidic Acid Production to Platelets and Mammalian Cells

Zachary Fulkerson et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid

Rodolphe Dusaulcy et al.

JOURNAL OF LIPID RESEARCH (2011)

Article Biochemical Research Methods

WGCNA: an R package for weighted correlation network analysis

Peter Langfelder et al.

BMC BIOINFORMATICS (2008)

Article Medical Laboratory Technology

Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity

Shigemi Hosogaya et al.

ANNALS OF CLINICAL BIOCHEMISTRY (2008)

Article Gastroenterology & Hepatology

Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C

Naoko Watanabe et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2007)

Article Cell & Tissue Engineering

Lysophosphatidic acid modulates the activation of human monocyte-derived dendritic cells

Rongbing Chen et al.

STEM CELLS AND DEVELOPMENT (2006)